Stuart Hawtin

1.4k citations

36 papers · 1.1k · h-index 20

Impact in

Endocrine and Autonomic Systems top 5%
- Circadian rhythm and melatonin
Cellular and Molecular Neuroscience top 5%
- Neuropeptides and Animal Physiology

Papers in

Molecular Biology 31
- Receptor Mechanisms and Signaling 19
- Melanoma and MAPK Pathways 5
- Amyloidosis: Diagnosis, Treatment, Outcomes 3
Social Psychology 21
- Neuroendocrine regulation and behavior 21

Co-authors: Mark S. Shearman (5 shared papers)Mark Wheatley (21 shared papers)Scott J. Pollack (3 shared papers)Rosemary A. Parslow (8 shared papers)Helen Howard (4 shared papers)John Simms (7 shared papers)Smita S. Patel (2 shared papers)Matthew T. Conner (3 shared papers)
Journals: Biochemical Society Transactions (7 papers)Bioorganic & Medicinal Chemistry Letters (4 papers)Biochemical Journal (4 papers)Journal of Biological Chemistry (4 papers)Molecular Endocrinology (3 papers)
Partner nations: United Kingdom Switzerland United States

In The Last Decade

Stuart Hawtin

35 papers receiving 1.1k citations

Peers

Countries citing papers authored by Stuart Hawtin

Since Specialization

Citations

This map shows the geographic impact of Stuart Hawtin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart Hawtin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart Hawtin more than expected).

Fields of papers citing papers by Stuart Hawtin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stuart Hawtin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart Hawtin. The network helps show where Stuart Hawtin may publish in the future.

Co-authors

The 25 scholars most cited alongside Stuart Hawtin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Stuart Hawtin Line = papers co-authored together Stuart Hawtin links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	The Intracellular Component of Cellular 3‐(4,5‐Dimethylthiazol‐2‐yl)‐2,5‐Diphenyltetrazolium Bromide (MTT) Reduction Is Specifically Inhibited by β‐Amyloid Peptides Journal of Neurochemistry ·Mark S. Shearman, Stuart Hawtin, Vipula J. Tailor	1995	192
2	Sulfated glycosaminoglycans and dyes attenuate the neurotoxic effects of β-amyloid in rat PC12 cells Neuroscience Letters ·Scott J. Pollack, Isobel I. J. Sadler, Stuart Hawtin, Vipula J. Tailor, Mark S. Shearman	1995	91
3	Sulfonated dyes attenuate the toxic effects of β-amyloid in a structure-specific fashion Neuroscience Letters ·Scott J. Pollack, Isobel I. J. Sadler, Stuart Hawtin, Vipula J. Tailor, Mark S. Shearman	1995	77
4	Systematic Analysis of the Entire Second Extracellular Loop of the V1a Vasopressin Receptor Journal of Biological Chemistry ·Matthew T. Conner, Stuart Hawtin, John Simms, Denise Wootten, Zoe Lawson, Alex C. Conner, Rosemary A. Parslow, Mark Wheatley	2007	69
5	Palmitoylation of the Vasopressin V1a Receptor Reveals Different Conformational Requirements for Signaling, Agonist-induced Receptor Phosphorylation, and Sequestration Journal of Biological Chemistry ·Stuart Hawtin, Andrew B. Tobin, Smita S. Patel, Mark Wheatley	2001	58
6	Curcumin: a new cell-permeant inhibitor of the inositol 1,4,5-trisphosphate receptor Cell Calcium ·Jeanette L. Dyer, Sajida Khan, Jonathan G. Bilmen, Stuart Hawtin, Mark Wheatley, Masood‐ul‐Hassan Javed, Francesco Michelangeli	2002	53
7	Charged Extracellular Residues, Conserved throughout a G-protein-coupled Receptor Family, Are Required for Ligand Binding, Receptor Activation, and Cell-surface Expression Journal of Biological Chemistry ·Stuart Hawtin, John Simms, Matthew T. Conner, Zoe Lawson, Rosemary A. Parslow, Julie E. Trim, Andrew Sheppard, Mark Wheatley	2006	38
8	Identification of the glycosylation sites utilized on the V1a vasopressin receptor and assessment of their role in receptor signalling and expression Biochemical Journal ·Stuart Hawtin, Andrew R. Davies, Glenn Matthews, Mark Wheatley	2001	36
9	Pyrrolo-pyrimidones: A novel class of MK2 inhibitors with potent cellular activity Bioorganic & Medicinal Chemistry Letters ·Achim Schlapbach, Roland Feifel, Stuart Hawtin, Richard Heng, Guido Koch, Henrik Moebitz, Láśzló Révész, Clemens Scheufler, Juraj Velcicky, Rudolf Waelchli, Christine Huppertz	2008	35
10	Novel 3-aminopyrazole inhibitors of MK-2 discovered by scaffold hopping strategy Bioorganic & Medicinal Chemistry Letters ·Juraj Velcicky, Roland Feifel, Stuart Hawtin, Richard Heng, Christine Huppertz, Guido Koch, M. Kroemer, Henrik Moebitz, Láśzló Révész, Clemens Scheufler, Achim Schlapbach	2009	35
11	Pharmacological Chaperone Activity of SR49059 to Functionally Recover Misfolded Mutations of the Vasopressin V1a Receptor Journal of Biological Chemistry ·Stuart Hawtin	2006	34
12	Agonist-Specific, High-Affinity Binding Epitopes Are Contributed by an Arginine in the N-Terminus of the Human Oxytocin Receptor Biochemistry ·Victoria J. Wesley, Stuart Hawtin, Helen Howard, Mark Wheatley	2002	34
13	Critical Role of a Subdomain of the N-Terminus of the V₁_a Vasopressin Receptor for Binding Agonists but Not Antagonists; Functional Rescue by the Oxytocin Receptor N-Terminus Biochemistry ·Stuart Hawtin, Victoria J. Wesley, Rosemary A. Parslow, Smita S. Patel, Mark Wheatley	2000	29
14	Chimeric strategies for the rational design of bioactive analogs of small peptide hormones The FASEB Journal ·John Howl, Ülo Langel, Stuart Hawtin, Andres Valkna, NICOLA. J. YARWOOD, Külliki Saar, Mark Wheatley	1997	28
15	In vivo and in vitro SAR of tetracyclic MAPKAP-K2 (MK2) inhibitors. Part II Bioorganic & Medicinal Chemistry Letters ·Láśzló Révész, Achim Schlapbach, Reiner Aichholz, Janet Dawson, Roland Feifel, Stuart Hawtin, Amanda Littlewood‐Evans, Guido Koch, M. Kroemer, Henrik Möbitz, Clemens Scheufler, Juraj Velcicky, Christine Huppertz	2010	27
16	Identification of an extracellular segment of the oxytocin receptor providing agonist-specific binding epitopes Biochemical Journal ·Stuart Hawtin, Helen Howard, Mark Wheatley	2001	25
17	In vivo and in vitro SAR of tetracyclic MAPKAP-K2 (MK2) inhibitors. Part I Bioorganic & Medicinal Chemistry Letters ·Láśzló Révész, Achim Schlapbach, Reiner Aichholz, Roland Feifel, Stuart Hawtin, Richard Heng, Peter Hiestand, Wolfgang Jahnke, Guido Koch, M. Kroemer, Henrik Möbitz, Clemens Scheufler, Juraj Velcicky, Christine Huppertz	2010	23
18	Extracellular loops and ligand binding to a subfamily of Family A G-protein-coupled receptors Biochemical Society Transactions ·Mark Wheatley, John Simms, Stuart Hawtin, Victoria J. Wesley, Denise Wootten, Matthew T. Conner, Zoe Lawson, Alex C. Conner, Andy Baker, Y. Cashmore, Robert Kendrick, Rosemary A. Parslow	2007	23
19	A Single Residue (Arg⁴⁶) Located Within the N-Terminus of the V_1aVasopressin Receptor Is Critical for Binding Vasopressin But Not Peptide or Nonpeptide Antagonists Molecular Endocrinology ·Stuart Hawtin, Victoria J. Wesley, Rosemary A. Parslow, John Simms, Alice Miles, Kim McEwan, Mark Wheatley	2002	22
20	Identification of an extracellular segment of the oxytocin receptor providing agonist-specific binding epitopes Biochemical Journal ·Stuart Hawtin, Helen Howard, Mark Wheatley	2001	19

About Stuart Hawtin

Stuart Hawtin is a scholar working on Molecular Biology, Social Psychology, Endocrine and Autonomic Systems, Cellular and Molecular Neuroscience and Organic Chemistry, having authored 36 papers that have together received 1.1k indexed citations. Recurring topics across this work include Neuroendocrine regulation and behavior (21 papers), Receptor Mechanisms and Signaling (19 papers), Circadian rhythm and melatonin (8 papers), Neuropeptides and Animal Physiology (6 papers), Melanoma and MAPK Pathways (5 papers), Alzheimer's disease research and treatments (3 papers), Synthesis and biological activity (3 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (3 papers). The work is most often cited by research in Endocrine and Autonomic Systems (138 citations), Cellular and Molecular Neuroscience (294 citations), Social Psychology (259 citations), Physiology (274 citations) and Molecular Biology (724 citations). Stuart Hawtin has collaborated with scholars based in United Kingdom, Switzerland and United States. Frequent co-authors include Mark S. Shearman, Mark Wheatley, Scott J. Pollack, Rosemary A. Parslow, Helen Howard, John Simms, Smita S. Patel, Matthew T. Conner, Andrew B. Tobin and Glenn Matthews. Their work appears in journals such as Biochemical Society Transactions, Bioorganic & Medicinal Chemistry Letters, Biochemical Journal, Journal of Biological Chemistry and Molecular Endocrinology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Stuart Hawtin

Impact in

Papers in i

In The Last Decade

Stuart Hawtin

Peers

Countries citing papers authored by Stuart Hawtin

Fields of papers citing papers by Stuart Hawtin

All Works

About Stuart Hawtin

Explore authors with similar magnitude of impact

Papers in